权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of the AMPK-MDMX-p53 pathway in cancer

AMPK-MDMX-p53 通路在癌症中的作用

基本信息

批准号：
9753938
负责人：
Hua Lu
金额：
$ 31.2万
依托单位：
TULANE UNIVERSITY OF LOUISIANA
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2021-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9753938
关键词：
Accounting Address Affect Animals Antineoplastic Agents Apoptosis Autophagocytosis Binding Biochemical Biological Models Brain Hypoxia-Ischemia Cells Cellular Stress Complex Defect Development Diet Drug Targeting Energy Metabolism Event Fasting Fatty Liver Feedback Future Genes Impairment Knock-in Knock-in Mouse Lead Light Lipids Liver MDM2 gene Malignant Neoplasms Metabolic Pathway Metabolic stress Metabolism Molecular Mus Normal Cell Nuclear Nucleic Acids Nutrient Oxygen Pathway interactions Phosphorylation Phosphotransferases Physiological Play Process Protein Kinase Protein p53 Proteins Regulation Ribosomal Interaction Ribosomal Proteins Ribosomes Role STK11 gene Serine Stress TP53 gene Testing Text Tumor Suppression Weight Gain amino acid metabolism base cancer cell cell growth cellular targeting design drug discovery genetic approach glucose metabolism insight lipid metabolism nutrient deprivation public health relevance response sensor tumor tumor growth tumor metabolism tumorigenesis

项目摘要

DESCRIPTION (provided by applicant): The importance of metabolism for cancer development and progression has been increasingly recognized over the past decade. Cancer cells undergo drastic alternations of metabolism, including metabolism of glucose and lipid, and oxidative responses. These processes are highly regulated by AMPK and p53. AMPK is activated by LKB1 and AMP/ADP in response to bio-energy shortage to coordinate metabolism, cell growth, apoptosis and autophagy by phosphorylating its target proteins. Also, the tumor suppressor p53 can be activated by this type of stress to confine metabolic pathways, which favor tumor growth, and to turn on cellular pathways that lead to cell growth arrest and apoptosis by inducing a variety of genes important for these functions. The anti-tumor function of p53 is tightly regulated by its two physiological antagonists MDM2 and MDMX, which form a complex to act as a negative feedback regulator of p53. Hence, blocking this feedback regulation is the key for cellular stresses to activate p53. For instance, ribosomal stress (RS) leads to p53 activation by inducing the interaction of ribosomal proteins L11 and L5 with MDM2 and restraining the latter's activity toward p53, but defect of this interaction in MDM2C305F mice impairs this pathway. Interestingly, AMPK can act as an upstream regulator of p53 upon metabolic stress by phosphorylating MDMX at Ser342, leading to inactivation of MDMX by inducing its binding to 14-3-3, consequently activating p53. Hence, our studies suggest that MDMX may function as a crucial player under metabolic stress. Also our preliminary studies using MDM2C305F and MDMX3SA double knock-in mice showed that the double impairments of the MDM2-MDMX-p53 pathways cause significant defects of lipid and glucose metabolisms in livers upon fasting. Thus, we hypothesize that the metabolic stress-AMPK-MDMX/RS-MDM2-p53 pathways may play an important role in regulation of metabolism in both normal and cancer cells upon metabolic stress. We will test this hypothesis by addressing three specific aims. 1. To elucidate mechanisms underlying the AMPK inhibition of MDMX activity toward p53 in response to metabolic stress. A) Does S342 phosphorylation by AMPK induce nuclear localization and degradation of MDMX? B) Does S342 phosphorylation by AMPK affect the formation of the MDMX-MDM2 complex? C) Does S342 phosphorylation by AMPK induce 14-3-3-binding to S367 of MDMX? 2. To determine if the AMPK-MDMX/RS-MDM2-p53 pathways play a role in regulation of metabolism in cells and mice. A. To determine if dual defects of the MDMX-MDM2-p53 pathway impair energy metabolism under physiological and stress conditions. B. To illustrate new p53 responsive genes important for regulation of lipid and glucose metabolism by the AMPK-MDMX/RS-MDM2-p53 pathways. 3. To determine if dual defects of the AMPK-MDMX/RS-MDM2-p53 pathways accelerate tumorigenesis in two mouse tumor model systems. Completing these studies would offer molecular insight into how lipid and glucose metabolism is controlled by this pathway, and also reveal new molecule targets for future anti-cancer drug discovery.

描述（由申请人提供）：在过去十年中，代谢对癌症发展和进展的重要性已得到越来越多的认识。癌细胞经历代谢的剧烈变化，包括葡萄糖和脂质的代谢以及氧化反应。这些过程受到AMPK和p53的高度调节。AMPK在生物能量缺乏时被LKB 1和AMP/ADP激活，通过磷酸化其靶蛋白来协调代谢、细胞生长、凋亡和自噬。此外，肿瘤抑制因子p53可以被这种类型的应激激活，以限制有利于肿瘤生长的代谢途径，并通过诱导对这些功能重要的各种基因来打开导致细胞生长停滞和凋亡的细胞途径。p53的抗肿瘤功能受到其两种生理拮抗剂MDM 2和MDMX的严格调节，这两种拮抗剂形成复合物以充当p53的负反馈调节剂。因此，阻断这种反馈调节是细胞应激激活p53的关键。例如，核糖体应激（RS）通过诱导核糖体蛋白L11和L5与MDM 2的相互作用并抑制后者对p53的活性而导致p53活化，但在MDM 2C 305 F小鼠中这种相互作用的缺陷损害了这一途径。有趣的是，AMPK可以在代谢应激时通过在Ser 342处磷酸化MDMX而充当p53的上游调节剂，通过诱导其与14-3-3结合而导致MDMX失活，从而激活p53。因此，我们的研究表明，MDMX可能在代谢应激下发挥关键作用。此外，我们使用MDM 2C 305 F和MDMX 3SA双敲入小鼠的初步研究表明，MDM 2-MDMX-p53途径的双重损伤导致禁食后肝脏中脂质和葡萄糖代谢的显著缺陷。因此，我们假设代谢应激-AMPK-MDMX/RS-MDM 2-p53途径可能在代谢应激下正常细胞和癌细胞的代谢调节中发挥重要作用。我们将通过解决三个具体目标来检验这一假设。1.阐明代谢应激时AMPK抑制MDMX对p53活性的潜在机制。A）通过AMPK的S342磷酸化是否诱导MDMX的核定位和降解？B）AMPK引起的S342磷酸化是否影响MDMX-MDM 2复合物的形成？C）通过AMPK的S342磷酸化是否诱导MDMX的14-3-3-结合至S367？2.确定AMPK-MDMX/RS-MDM 2-p53通路是否在细胞和小鼠的代谢调节中发挥作用。A.确定MDMX-MDM 2-p53通路的双重缺陷是否损害生理和应激条件下的能量代谢。B。阐明通过AMPK-MDMX/RS-MDM 2-p53途径调节脂质和葡萄糖代谢的重要新p53应答基因。3.确定AMPK-MDMX/RS-MDM 2-p53通路的双重缺陷是否加速两种小鼠肿瘤模型系统中的肿瘤发生。完成这些研究将提供对脂质和葡萄糖代谢如何由该途径控制的分子见解，并为未来的抗癌药物发现揭示新的分子靶点。